The current price of CELU is $0.7601 — it has increased by 4.80% since the previous close. Data as of Nov 6, 2026.
CELU is down 4.99% over the past week, down 48.29% over the past month and down 57.30% over the past year. The price is below its 200-day moving average of $1.07.
Celularity Inc. has a market capitalization of $24.67M. The company belongs to the Healthcare sector. Compare it with other companies in the stock screener.
In its most recent quarterly report, Celularity Inc. posted a loss of $0.12 per share. Upcoming reports are listed in the earnings calendar.
Companies most comparable to Celularity Inc. include PolyPid Ltd., Kezar Life Sciences, Inc., Actinium Pharmaceuticals, Inc., FibroGen, Inc. and Generation Bio Co.
In the latest trading session CELU moved between $0.7243 and $0.769, a range of 5.88% of its current price.
Investing in stocks requires thorough research: study the company's financials, related news and technical analysis before making a decision. Technical analysis of Celularity Inc. shows a sell rating today and a strong sell rating on the weekly timeframe. Market conditions change quickly, so it is worth looking further ahead as well — the 1-month rating for Celularity Inc. is sell. Technical ratings are indicators, not investment advice.
Over the past 52 weeks CELU has traded between $0.5601 and $2.55. The current price is 70.19% below its 52-week high.
Figures as of Nov 6, 2026. This information is provided for general purposes only and is not investment advice.